Science & Technology
Neurogen Biomarking Virtual Care Ecosystem Cuts Time to Alzheimer’s Intervention by 4.5 Years
Elisabeth Thijssen, PhD, Chief Scientific Officer of Neurogen Biomarking. What You Ought to Know: – Developments in accelerating early Alzheimer’s